Sunshine Biopharma Inc (SBFM)

[MikeD]

SBFM is dangling potentially getting the QB status but at the same time is still listed as a Shell Risk designation company on the OTC website. It seems to improve their chances to make the jump to up-list to QB designation within the OTC and legitimize the company and its financing further, the next step would of been to take the measures to remove the Shell Risk designation within the OTC. To remove Shell Risk designation it just takes at times a letter to the OTC from the company letting them know of their improvements. “The Shell Risk designation indicates that a company displays characteristics common to Shell Companies. This designation is made at OTC Markets’ sole and absolute discretion based on an analysis of the company’s annual financial data and may differ from issuers’ self-reported shell classifications in their own public filings. Our analysis evaluates asset composition, operational expenditures, and income related metrics. No action is required by a company to perform the evaluation other than publishing current annual financial information.
In limited circumstances, OTC Markets will consider removal of a company’s shell risk designation upon written request by a company. Please be advised that such requests will only be considered when there has been a material change in financial condition since the most recent fiscal year-end that is reflected in publicly available interim financial statements. Examples include a material increase in asset composition or operating revenues with related financial disclosure as a result of an acquisition or change in control transaction.” All IMO

https://www.otcmarkets.com/glossary